Revenue growth has contracted significantly, with the company reporting a 2026Q4 revenue of $42.8M and a negative operating margin of -13.3%.
| Metric | Mar'26 | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Mar'09 | Mar'08 | Mar'07 | Mar'06 | Mar'05 | Mar'04 | Mar'03 | Mar'02 | Mar'01 | Mar'00 |
|---|
| Sales/Revenue | 179.02M | 226.97M | 274.1M | 256.58M | 273.42M | 303.58M | 284.13M | 283.42M | 273.8M | 249.18M | 234.68M | 229.4M | 233.39M | 227.83M | 238.25M | 231.64M | 238.27M | 219.41M | 188.34M | 162.25M | 137.58M | 108.36M | 93.99M | 54.97M | 32.03M | 10.01M | 14.68M |
| Revenue Growth % | -21.13% | -17.19% | 6.83% | -6.16% | -9.94% | 6.85% | 0.25% | 3.51% | 9.88% | 6.18% | 2.31% | -1.71% | 2.44% | -4.37% | 2.85% | -2.78% | 8.59% | 16.5% | 16.08% | 17.93% | 26.97% | 15.28% | 70.98% | 71.66% | 220.06% | -31.82% | - |
| Cost of Goods Sold | 128.81M | 157.84M | 196.38M | 185.84M | 198.08M | 219.27M | 202.88M | 188.1M | 175.99M | 169.86M | 158.39M | 153.13M | 155.77M | 150.71M | 158.09M | 147.69M | 146.41M | 134.08M | 114.12M | 97.68M | 83.24M | 64.7M | 55.82M | 31.52M | 18.89M | 6.37M | 9.06M |
| COGS % of Revenue | 71.95% | 69.54% | 71.65% | 72.43% | 72.45% | 72.23% | 71.4% | 66.37% | 64.28% | 68.17% | 67.49% | 66.75% | 66.74% | 66.15% | 66.35% | 63.76% | 61.45% | 61.11% | 60.59% | 60.2% | 60.5% | 59.71% | 59.39% | 57.33% | 59% | 63.64% | 61.74% |
| Gross Profit | 50.22M | 69.14M | 77.71M | 71.01M | 75.34M | 84.32M | 81.25M | 95.31M | 97.81M | 79.31M | 76.3M | 76.27M | 77.62M | 77.12M | 80.17M | 83.96M | 91.86M | 85.33M | 74.21M | 64.57M | 54.34M | 43.66M | 38.17M | 23.46M | 13.13M | 3.64M | 5.62M |
| Gross Margin % | 28.05% | 30.46% | 28.35% | 27.68% | 27.55% | 27.77% | 28.6% | 33.63% | 35.72% | 31.83% | 32.51% | 33.25% | 33.26% | 33.85% | 33.65% | 36.24% | 38.55% | 38.89% | 39.41% | 39.8% | 39.5% | 40.29% | 40.61% | 42.67% | 41% | 36.36% | 38.26% |
| Gross Profit Growth % | -27.37% | -11.03% | 9.43% | -5.74% | -10.65% | 3.78% | -14.76% | -2.55% | 23.32% | 3.96% | 0.03% | -1.74% | 0.64% | -3.8% | -4.52% | -8.61% | 7.66% | 14.97% | 14.94% | 18.82% | 24.47% | 14.38% | 62.72% | 78.63% | 260.88% | -35.2% | - |
| Operating Expenses | 72.24M | 70.67M | 84.67M | 64.68M | 49.63M | 53.78M | 50.27M | 49.14M | 45.67M | 41.83M | 43.91M | 46.94M | 49.4M | 50.12M | 54.14M | 50.93M | 51.32M | 51.13M | 46.22M | 43.07M | 36.19M | 31.16M | 28.96M | 19.97M | 12.38M | 6.28M | 7.2M |
| OpEx % of Revenue | 40.36% | 31.13% | 30.89% | 25.21% | 18.15% | 17.72% | 17.69% | 17.34% | 16.68% | 16.79% | 18.71% | 20.46% | 21.17% | 22% | 22.73% | 21.99% | 21.54% | 23.3% | 24.54% | 26.54% | 26.31% | 28.75% | 30.81% | 36.33% | 38.67% | 62.74% | 49.06% |
| Selling, General & Admin | 72.24M | 62.43M | 79.75M | 68.9M | 49.63M | 49.93M | 48.01M | 46.91M | 43.55M | 40.46M | 43.14M | 46.28M | 48.53M | 49.02M | 52.73M | 49.56M | 50M | 50.31M | 45.63M | 42.54M | 35.65M | 30.58M | 28.41M | 19.61M | 11.81M | 5.9M | 7.37M |
| SG&A % of Revenue | 40.36% | 27.5% | 29.1% | 26.85% | 18.15% | 16.45% | 16.9% | 16.55% | 15.9% | 16.24% | 18.38% | 20.18% | 20.79% | 21.52% | 22.13% | 21.39% | 20.98% | 22.93% | 24.23% | 26.22% | 25.91% | 28.22% | 30.22% | 35.66% | 36.88% | 59% | 50.22% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 8.24M | 4.92M | -4.21M | 0 | 3.85M | 2.26M | 2.23M | 2.13M | 1.37M | 770K | 2.37M | 867K | 1.09M | 1.41M | 1.38M | 1.32M | 814.54K | 589.99K | 530.44K | 544.53K | 573.82K | 550.39K | 367.67K | 571.76K | 373.85K | -169.98K |
| Operating Income | -31.41M | -1.53M | -6.96M | 6.55M | 25.71M | 30.53M | 30.98M | 46.17M | 52.14M | 37.48M | 32.39M | 27.61M | 28.22M | 27M | 26.02M | 33.02M | 40.54M | 34.2M | 28M | 21.5M | 18.15M | 12.5M | 9.21M | 3.48M | 747.94K | -2.64M | -1.59M |
| Operating Margin % | -17.55% | -0.67% | -2.54% | 2.55% | 9.4% | 10.06% | 10.9% | 16.29% | 19.04% | 15.04% | 13.8% | 12.04% | 12.09% | 11.85% | 10.92% | 14.26% | 17.02% | 15.59% | 14.86% | 13.25% | 13.19% | 11.54% | 9.8% | 6.34% | 2.34% | -26.37% | -10.8% |
| Operating Income Growth % | -1953.27% | 78.02% | -206.27% | -74.52% | -15.79% | -1.44% | -32.91% | -11.44% | 39.09% | 15.73% | 17.29% | -2.14% | 4.49% | 3.78% | -21.2% | -18.54% | 18.54% | 22.17% | 30.21% | 18.49% | 45.14% | 35.72% | 164.47% | 365.68% | 128.34% | -66.45% | - |
| EBITDA | -22.03M | 5.51M | 94K | 10.1M | 28.45M | 32.96M | 33.23M | 48.4M | 54.26M | 38.85M | 33.16M | 28.27M | 29.09M | 28.1M | 27.43M | 34.4M | 41.86M | 35.02M | 28.59M | 22.03M | 18.69M | 13.08M | 9.76M | 3.85M | 984.65K | -2.73M | -1.76M |
| EBITDA Margin % | -12.3% | 2.43% | 0.03% | 3.94% | 10.4% | 10.86% | 11.7% | 17.08% | 19.82% | 15.59% | 14.13% | 12.32% | 12.46% | 12.33% | 11.51% | 14.85% | 17.57% | 15.96% | 15.18% | 13.58% | 13.58% | 12.07% | 10.39% | 7% | 3.07% | -27.26% | -11.96% |
| EBITDA Growth % | -499.85% | 5760.64% | -99.07% | -64.51% | -13.68% | -0.83% | -31.33% | -10.8% | 39.66% | 17.17% | 17.28% | -2.79% | 3.52% | 2.42% | -20.25% | -17.83% | 19.56% | 22.49% | 29.75% | 17.87% | 42.94% | 33.95% | 153.51% | 291.07% | 136.1% | -55.36% | - |
| D&A (Non-Cash Add-back) | 9.39M | 7.04M | 7.06M | 3.55M | 2.74M | 2.43M | 2.26M | 2.23M | 2.13M | 1.37M | 770K | 660K | 867K | 1.09M | 1.41M | 1.38M | 1.32M | 814.54K | 589.99K | 530.44K | 544.53K | 573.82K | 550.39K | 367.67K | 236.72K | -88.29K | -169.98K |
| EBIT | -31.41M | -330K | -6.27M | 7.45M | 27.07M | 30.53M | 33.89M | 49.12M | 53.79M | 37.92M | 32.39M | 29.33M | 28.4M | 27.31M | 26.02M | 33.02M | 40.54M | 34.2M | 28M | 21.5M | 18.15M | 12.5M | 9.21M | 3.48M | 747.94K | -2.64M | -1.59M |
| Net Interest Income | 511K | 0 | 511K | 450K | 335K | -896K | 1.75M | 1.86M | 658K | 141K | 190K | 184K | 185K | 306K | 288K | 381K | 196K | 1.06M | 1.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 511K | 0 | 511K | 450K | 335K | 314K | 1.75M | 1.86M | 658K | 141K | 190K | 184K | 185K | 306K | 288K | 381K | 196K | 1.06M | 1.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 1.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.6K | 0 | 187.61K | 14.35K |
| Other Income/Expense | -25.94M | 943K | 689K | 894K | 1.36M | 419K | 2.92M | 2.95M | 1.65M | 441K | 179K | 185K | 181K | 301K | 349K | 253K | 200K | 1.46M | 2.42M | 1.7M | 889.95K | 101.79K | 2.13K | -2.6K | 77.47K | -187.61K | -14.35K |
| Pretax Income | -57.36M | -587K | -6.27M | 7.45M | 27.07M | 30.95M | 33.89M | 49.12M | 53.79M | 37.92M | 32.57M | 27.8M | 28.4M | 27.31M | 26.37M | 33.28M | 40.74M | 35.66M | 30.41M | 23.2M | 19.04M | 12.6M | 9.21M | 3.48M | 825.41K | -2.83M | -1.6M |
| Pretax Margin % | -32.04% | -0.26% | -2.29% | 2.9% | 9.9% | 10.19% | 11.93% | 17.33% | 19.65% | 15.22% | 13.88% | 12.12% | 12.17% | 11.99% | 11.07% | 14.37% | 17.1% | 16.25% | 16.15% | 14.3% | 13.84% | 11.63% | 9.8% | 6.33% | 2.58% | -28.25% | -10.9% |
| Income Tax | -73K | 5.68M | 1.19M | 2.31M | 5.97M | 7.03M | 8.04M | 11.38M | 16.51M | 14.11M | 12M | 10.35M | 10.43M | 10.14M | 9.71M | 12.41M | 14.74M | 12.68M | 10.39M | 8.76M | 6.97M | 4.59M | 3.4M | 222.84K | 0 | 0 | 208.68K |
| Effective Tax Rate % | 0.13% | -968.31% | -18.99% | 30.96% | 22.06% | 22.72% | 23.73% | 23.17% | 30.69% | 37.19% | 36.85% | 37.21% | 36.72% | 37.14% | 36.83% | 37.28% | 36.18% | 35.56% | 34.16% | 37.75% | 36.63% | 36.44% | 36.9% | 6.4% | 0% | 0% | -13.04% |
| Net Income | -57.29M | -6.27M | -7.46M | 5.14M | 21.1M | 23.92M | 25.85M | 37.74M | 37.28M | 23.82M | 20.57M | 17.45M | 17.97M | 17.16M | 16.66M | 20.87M | 26M | 22.98M | 20.02M | 14.44M | 12.06M | 8.01M | 5.81M | 3.26M | 825.41K | -2.83M | -1.79M |
| Net Margin % | -32% | -2.76% | -2.72% | 2% | 7.72% | 7.88% | 9.1% | 13.32% | 13.62% | 9.56% | 8.76% | 7.61% | 7.7% | 7.53% | 6.99% | 9.01% | 10.91% | 10.47% | 10.63% | 8.9% | 8.77% | 7.39% | 6.19% | 5.93% | 2.58% | -28.25% | -12.22% |
| Net Income Growth % | -813.51% | 15.98% | -245.21% | -75.64% | -11.79% | -7.47% | -31.5% | 1.23% | 56.53% | 15.81% | 17.84% | -2.89% | 4.7% | 3.04% | -20.18% | -19.73% | 13.17% | 14.75% | 38.62% | 19.73% | 50.6% | 37.79% | 78.46% | 294.66% | 129.2% | -57.54% | - |
| Net Income (Continuing) | -57.29M | -6.27M | -7.46M | 5.14M | 21.1M | 23.92M | 25.85M | 37.74M | 37.28M | 23.82M | 20.57M | 17.45M | 17.97M | 17.16M | 16.66M | 20.87M | 26M | 22.98M | 20.02M | 14.44M | 12.06M | 8.01M | 5.81M | 3.26M | 825.41K | -2.83M | -1.79M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.74 | -0.30 | -0.37 | 0.25 | 1.04 | 1.52 | 1.29 | 1.84 | 1.82 | 1.17 | 1.02 | 0.87 | 0.90 | 0.86 | 0.80 | 0.92 | 1.14 | 0.98 | 0.82 | 0.60 | 0.50 | 0.34 | 0.25 | 0.16 | 0.04 | -0.28 | -0.28 |
| EPS Growth % | -813.33% | 18.92% | -248% | -75.96% | -31.58% | 17.83% | -29.89% | 1.1% | 55.56% | 14.71% | 17.24% | -3.33% | 4.65% | 7.5% | -13.04% | -19.3% | 16.33% | 19.51% | 36.67% | 20% | 47.06% | 36% | 56.25% | 300% | 114.29% | 0% | - |
| EPS (Basic) | -2.74 | -0.30 | -0.37 | 0.25 | 1.05 | 1.53 | 1.29 | 1.84 | 1.83 | 1.18 | 1.02 | 0.87 | 0.90 | 0.86 | 0.81 | 0.93 | 1.15 | 0.99 | 0.83 | 0.60 | 0.51 | 0.35 | 0.30 | 0.19 | 0.05 | -0.28 | -0.28 |
| Diluted Shares Outstanding | 20.92M | 20.6M | 20.4M | 20.34M | 20.36M | 20.12M | 20.05M | 20.49M | 20.43M | 20.38M | 20.25M | 20.14M | 20.04M | 20.05M | 20.71M | 22.64M | 22.75M | 23.48M | 24.3M | 24.27M | 24.21M | 23.83M | 23.69M | 20.75M | 19.74M | 9.94M | 6.37M |
| Basic Shares Outstanding | 20.92M | 20.6M | 20.4M | 20.27M | 20.18M | 20.06M | 20.04M | 20.46M | 20.35M | 20.23M | 20.12M | 20.02M | 19.9M | 19.93M | 20.61M | 22.51M | 22.62M | 23.31M | 24.09M | 24.11M | 23.66M | 22.86M | 19.47M | 17.3M | 16.36M | 9.94M | 6.37M |
| Dividend Payout Ratio | - | - | - | 477.37% | 115.56% | 94.85% | 84.34% | 58.09% | 46.86% | 65.11% | 71.4% | 79.11% | 74.15% | 186.26% | 65.81% | 51.4% | 26.17% | - | - | - | - | - | - | - | - | - | - |
Liquidity and customer churn
As reported in recent financial filings, PETS experienced a sustained revenue decline, culminating in a 21.13% year-over-year drop, which suggests that the company's legacy transactional model is failing to retain its active customer base against more integrated, subscription-heavy e-commerce competitors in the pet pharmacy space.
The consistent quarterly revenue decay indicates that the company's value proposition is losing relevance in a market increasingly dominated by ecosystem-based platforms. Investors should monitor whether the decline in top-line performance reflects a permanent loss of market share or a temporary failure to adapt to modern digital fulfillment expectations.
Based on the company's reported figures, gross margins have fluctuated significantly, reaching a low of 23.3% in 2026Q3, which highlights the company's inability to maintain pricing power or effectively manage the rising logistics costs inherent in its specialized pharmacy fulfillment model.
The volatility in gross margins suggests that the company lacks the scale to offset third-party carrier rate increases or competitive pricing pressures. This instability in core profitability implies that the business model may be structurally disadvantaged compared to larger peers with more diversified revenue streams.
According to the provided income statement data, operating margins have deteriorated into negative territory, reaching -17.55% as the company fails to scale its fixed overhead costs against a rapidly shrinking revenue base, signaling a breakdown in traditional operating leverage efficiency.
The inability to reduce SG&A expenses in proportion to the revenue decline suggests that the company's cost structure is increasingly rigid. This trend warrants further investigation into whether management can successfully pivot to a leaner operating model before the current cash burn exhausts available liquidity.
As indicated by the financial statements, the company has shifted from a dividend-paying entity to one reporting a -32.00% net margin, with significant quarterly volatility in net income that appears heavily influenced by non-operating items and potential restructuring charges related to recent acquisitions.
The transition to deep net losses suggests that the company's historical profitability was likely tied to a business environment that no longer exists. Investors should be wary of the quality of these earnings, as the lack of consistent positive net income makes traditional valuation metrics like P/E ratios currently inapplicable.
Based on the reported figures, the company's cash reserves of $21.4M appear insufficient to sustain the current burn rate, which reached a significant net loss in recent quarters, suggesting that the firm may face a liquidity crunch within the next 12 to 18 months.
While some may argue that the company's pharmacy data holds strategic value for an acquirer, the current financial trajectory suggests a high risk of insolvency if the core business does not stabilize. The market appears to be pricing in a distressed scenario, reflecting the reality that the company's current cash position provides a very narrow margin for error.
Quick answers to the most common questions about buying PETS stock.
For fiscal year 2026, PetMed Express, Inc. (PETS) reported total revenue of $179.0M. This represents a 1119.7% increase compared to $14.7M in 2000.
PetMed Express, Inc. (PETS) reported a net loss of $57.3M for the fiscal year ending 2026.
PetMed Express, Inc. (PETS) reported an operating income of $-31.4M, resulting in an operating profit margin of -17.5%. This margin reflects the operational efficiency of the business before interest and taxes.
PetMed Express, Inc. (PETS) generated $50.2M in gross profit for the year, representing a gross profit margin of 28.1%. This demonstrates the company's core pricing power and production efficiency.